Expert Opinion on Biological Therapy
Expert Opinion on Biological Therapy is a monthly peer-reviewed medical journal covering research on all aspects of biological therapy, including gene therapy and gene transfer technologies, therapeutic peptides and proteins, vaccines and antibodies, and cell- and tissue-based therapies. The journal is published by Taylor & Francis and the editor-in-chief is Michael Morse (Duke University Hospital). The journal was established in 2001 and according to the Journal Citation Reports, it has a 2017 impact factor of 3.974.[1] The journal is also indexed in MEDLINE.
| Discipline | Therapeutics |
|---|---|
| Language | English |
| Edited by | Michael Morse |
| Publication details | |
| History | 2001-present |
| Publisher | |
| Frequency | Monthly |
| 3.974 (2017) | |
| Standard abbreviations | |
| ISO 4 | Expert Opin. Biol. Ther. |
| Indexing | |
| ISSN | 1471-2598 (print) 1744-7682 (web) |
| LCCN | 2001243388 |
| OCLC no. | 48476209 |
| Links | |
References
- "Expert Opinion on Biological Therapy". 2017 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2018.
External links
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.